You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Loading...

13:00 - 18:00
Pre-Congress Course in Pediatric Gastroenterology
13:00 - 13:10
Opening Session

13:10 - 14:25
SESSION 1 – Pediatric IBD: Specific Considerations


Moderador(a)


 


 

13:10 - 13:25
Management of Acute Severe Colitis


 

13:25 - 13:45
Vaccination in IBD: What Can Complicate It?


 

13:45 - 14:15
Crohn’s Disease: Strictures


 

13:45 - 14:15
Perianal Disease: Diagnosis and Treatment


 

14:15 - 14:25
Discussion

14:25 - 14:55
Satellite Symposium

14:55 - 15:40
Session 2 – Maintenance Therapy Beyond Anti-TNFs


Moderador(a)


 


 

14:55 - 15:10
Crohn’s Disease


 

15:10 - 15:25
Ulcerative Colitis


 

15:25 - 15:35
VEO-IBD (Very Early-Onset Inflammatory Bowel Disease)


 

15:35 - 15:45
Discussion

15:45 - 16:00
BREAK

16:00 - 17:00
SESSION 3 – Special Considerations in Laboratory Evaluation in Children


Moderador(a)


 

16:00 - 16:20
Radiologist


 

16:20 - 16:40
Endoscopist


 

16:40 - 17:00
Pathologist


 

17:00 - 18:00
Session 4 – What Should We Do Now? Decision-Making in Challenging Cases


Moderador(a)


 


 


 


 


 


 

17:00 - 17:20
Case 1


 

17:20 - 17:40
Case 2


 

17:40 - 18:00
Case 3


 

18:00 - 18:30
Closing Session

13:00 - 19:00
Pre-Congress Course in Nutrition
13:00 - 13:10
Opening Session

13:10 - 14:25
Session 1 – Practical Updates in Nutrition for IBD: Update of the GEDIIB Brazilian Consensus on Nutrition and IBD


Moderador(a)


 


 

13:10 - 13:25
Luminal Crohn’s Disease


 

13:25 - 13:40
Complicated Crohn’s Disease


 

13:40 - 13:55
Active Ulcerative Colitis


 

13:55 - 14:10
IBD in Remission


 

14:10 - 14:25
Discussion

14:25 - 14:55
Symposium 1 – Nestlé

From the office to clinical practice: how nutrition impacted the management of a Crohn's disease case

Vanessa Scheeffer

14:55 - 15:40
SESSION 2


Moderador(a)


 


 

14:55 - 15:25
The Impact of Metabolic Disease on IBD


 

15:25 - 15:40
Discussion

15:40 - 16:00
BREAK

16:00 - 17:05
SESSION 3 – Microbiota and IBD


Moderador(a)


 


 

16:00 - 16:05
Case Presentation


 

16:05 - 16:20
Gut Microbiota and IBD


 

16:20 - 16:35
Food Additives and IBD


 

16:35 - 16:50
The Role of Diet in Gut Microbiota and IBD


 

16:50 - 17:05
Discussion

17:05 - 18:10
SESSION 4 – The Hospitalized Patient with IBD


Debatedor(a)


 

17:05 - 17:10
Case Presentation


 

17:10 - 17:25
Enteral and Parenteral Nutrition


 

17:25 - 17:40
Perioperative Care


 

17:40 - 17:55
Evidence on the Impact of Nutrition on Surgical Outcomes


 

17:55 - 18:10
Discussion

18:10 - 18:20
Closing Session

08:30 - 18:00
Pre-Congress Hands-On Course in Intestinal Ultrasound
08:30 - 09:00
Opening Session: Participant registration, networking, and official opening with presentation of the course objectives.

09:00 - 09:15
Pre-Course Assessment: Evaluation of baseline knowledge to assess participants’ prior understanding of intestinal ultrasound.


Palestrante


 


 


 


 


 


 

09:15 - 10:00
Theoretical Session 1: Fundamentals of Intestinal Ultrasound: Physical principles, image optimization, scanning protocols, and examination standardization.


 

10:00 - 10:45
Theoretical Session 2: Gastrointestinal Ultrasonographic Anatomy: Intestinal wall layers and normal patterns.


 

10:45 - 11:00
BREAK

11:00 - 11:45
Theoretical Session 3: Clinical Applications in IBD: Crohn’s disease and ulcerative colitis, including inflammatory activity and complications.


Palestrante


 


 

11:45 - 12:30
Theoretical Session 4: Case Discussion with Clinical–Radiological Correlation and Decision-Making


Palestrante


 


 

12:30 - 14:00
BREAK

14:00 - 16:00
Station Rotation

16:00 - 16:30
BREAK

16:30 - 17:00
Station Rotation

17:30 - 18:00
Final Assessment and Discussion

18:00 - 18:30
Closing Session

19:00 - 22:00
Congress
19:00 - 19:45
SEBRADII Opening Ceremony

19:45 - 20:05
Treatment-Naive or Early Intervention: From Scientific Evidence to Real-World Practice


Apresentador(a)


 

20:05 - 20:25
Optimizing the treatment of Inflammatory Bowel Disease


 

20:25 - 20:35
Discussion


Moderador(a)


 

20:45 - 22:00
Institutional Activity

07:45 - 18:30
Congress
07:45 - 09:30
Block 1: Head-to-Head Session


Moderador(a)


 


 

07:45 - 07:55
Disease Monitoring - Endoscopy as the Mandatory Gold Standard


 

07:55 - 08:05
Disease Monitoring - Non-Invasive Strategies (IUS + Biomarkers)


 

08:05 - 08:10
Discussion

08:10 - 08:20
Intra-abdominal Abscesses - Surgical Management


 

08:20 - 08:30
Intra-abdominal Abscesses - Conservative Management


 

08:30 - 08:35
Discussion

08:35 - 08:45
JAK Inhibitor Positioning - Early-Line JAK Inhibitors


 

08:45 - 08:55
JAK Inhibitor Positioning - Reserving for Post-Biologic Failure


 

08:55 - 09:00
Discussion

09:00 - 09:10
Difficult-to-Manage Ulcerative Colitis (UC) - Combination Advanced Therapies


 

09:10 - 09:20
Difficult-to-Manage Ulcerative Colitis (UC) - Colectomy


 

09:20 - 09:25
Discussion

09:30 - 10:00
Break – Booth Visit

10:00 - 10:45
Satellite Symposium 1 – Abbvie

The New Era of IBD with RINVOQ® (upadacitinib): from rapid response to deep control

Peter Bossuyt (Belgium)
Paulo Kotze

10:45 - 12:00
Block 2: Modern Monitoring


Moderador(a)


 


 

10:45 - 11:00
Following patients with IBD closer from a distance


 

11:00 - 11:15
Role of therapeutic drug monitoring in Inflammatory Bowel Disease


 

11:15 - 11:25
Timing for IUS in Disease Monitoring


 

11:25 - 11:40
Disease Clearance: How deep should we go?


 

11:40 - 12:00
Discussion

12:00 - 14:00
BREAK

12:30 - 13:15
Satellite Symposium 2 - Johnson & Johnson

IL-23 Inhibition in Crohn’s Disease: emerging evidence and future perspectives

Adam Cheifetz (USA)
Monique Kurtz

13:15 - 14:00
Satellite Symposium 3 - Johnson & Johnson

When does experience transform into a legacy?

Ligia Sassaki and Elizete Lomazi
Monique Kurtz

14:00 - 15:15
Block 3: Surgical Frontiers and Perianal Disease


Moderador(a)


 


 

14:00 - 14:15
What Every Clinician Needs to Know About IBD Surgery


 

14:15 - 14:25
Appendectomy in UC: Research or Reality?


 

14:25 - 14:40
Perianal Crohn's Disease: TOPCLASS for Clinicians and Surgeons


 

14:40 - 14:55
LIRIC: 10 Years Later and Robotic Surgery in IBD – Where Are We Now?


 

14:55 - 15:15
Discussion

15:15 - 15:30
Crohn's Disease Management based on New ACG Guidelines


 

15:30 - 15:45
Discussion

15:45 - 16:15
BREAK

16:15 - 17:00
Satellite Symposium 4 – Takeda

Raising the Bar in Ulcerative Colitis Treatment (VERDICT)
Vipul Jairath (CANADA)
Paulo Kotze

17:00 - 18:30
Block 4: Challenges in Ulcerative Colitis


Moderador(a)


 


 

17:00 - 17:12
Mild-to-Moderate Disease: Optimizing Treatment Outcomes


 

17:12 - 17:24
Positioning of Advanced therapies in moderate to severe ulcerative colitis


 

17:24 - 17:36
Current role of histology in the treatment of IBD: do neutrophils matter?


 

17:36 - 17:48
Dysplasia in UC: Endoscopic Advances and AI Applications


 

17:48 - 18:00
Non-Consensus Scenarios in Acute Severe Colitis Management


 

18:00 - 18:30
Discussion

07:00 - 19:30
Scientific Arena
08:00 - 09:30
Module: IBD Nursing - Part 1

08:00 - 08:15
Health Education and Self-Care in Patients with IBD


 

08:15 - 08:30
Safe Discharge Planning in Fistulizing Crohn's Disease


 

08:30 - 08:45
What Your Nurse Needs to Know to Excel in IBD


 

08:45 - 09:00
Integrated Care Models for IBD


 

09:00 - 09:30
Discussion


Moderador(a)


 

09:30 - 10:00
Sponsored Lecture – Biopas

Mirikizumab: what we have learned from international experience and the first Brazilian cases

Alexandre Carlos
Fernando Magro (PORTUGAL)

10:00 - 10:45
Sponsored Lecture – AbbVie

The Role of Nutrition in the Management of Inflammatory Bowel Diseases: A Multidisciplinary Perspective

Julio Baima
Moderator: Daniéla Magro

10:45 - 12:00
Module: Surgery in IBD - Part 1: Clinical Case - Anal Incontinence in a Patient with Crohn's Disease


Moderador(a)


 

10:45 - 10:50
Case Presentation


Apresentador(a)


 

10:50 - 11:00
Nutritionist's Approach


 

11:00 - 11:10
Pelvic Floor Physiotherapy Approach


 

11:10 - 11:20
Minimally Invasive Surgery Approach


 

11:20 - 11:30
Sacral Neuromodulation for Anal Incontinence


 

11:30 - 12:00
Discussion

12:15 - 13:15
Module: Endoscopy in IBD - Part 1: When the Mucosa Speaks Louder - What Does Endoscopy Decide in IBD?


Moderador(a)


 

12:15 - 12:30
Endoscopic Remission: Are We Assessing It Correctly?


 

12:30 - 12:45
Endoscopic Scores in Practice (Mayo, SES-CD, UCEIS, Rutgeerts)


 

12:45 - 13:00
When to Repeat Colonoscopy to Assess Therapeutic Response? The Mucosa Changed: Should I Change Therapy?


 

13:00 - 13:15
Discussion

13:30 - 14:00
Epidemiology of Pediatric IBD in Brazil: What National SUS Databases Reveal


 

14:00 - 15:00
Nutrition and Psychosomatic Aspects

14:00 - 14:13
Avoidant/Restrictive Food Intake Disorder (ARFID) and IBD


 

14:13 - 14:26
Binge Eating in IBD


 

14:26 - 14:39
Sarcopenia and Sarcopenic Obesity in the Context of IBD


 

14:39 - 15:00
Nutritional and Psychosomatic Approach in IBD


 

15:00 - 16:00
Module: Endoscopy in IBD - Part 2: Panel Discussion


Moderador(a)


 


Debatedor(a)


 


 


 


 

15:00 - 15:12
Between the Stricture and the Scalpel: The Role of Endoscopy in Crohn's Strictures

15:12 - 15:24
Dysplasia in IBD: Are We Seeing Everything?

15:24 - 15:36
Endoscopy That Changes Management

15:36 - 15:48
Difficult Colonoscopy in IBD: How to Complete the Exam Safely

15:58 - 16:00
Discussion

16:00 - 16:30
Satellite Symposium – Nestlé

Nutrition as Therapy in Crohn's Disease: From Scientific Evidence to Clinical Practice in Children and Adults

Joint presentation by two speakers:

Roberta Fragoso
Mikaell Faria

16:30 - 17:30
Sender Miszputen Award - Finalists in the Medicine and Multidisciplinary categories

Finalists – Medicine Category
Moderator: Ligia Sassaki

16:30 - 16:40
Perianal Abscess in Inflammatory Bowel Disease and Hidradenitis Suppurativa: Differences, Diagnostic Challenges, and Phenotype Overlap
Lucy Junka Yamamoto

16:40 - 16:50
Clinical factors associated with disability in patients with inflammatory bowel disease: assessment using IBD-DISK at a referral center
Beatriz Zambianco Parra

16:50 - 17:00
Mucosal expression patterns of microRNA-21 and let-7d are associated with response to infliximab in Crohn's disease
Marley Ribeiro Feitosa

Voting

Finalists – Multidisciplinary Category
Moderator: Daniéla Magro

17:00 - 17:10
Tissue-Specific Molecular Signatures and Regulatory T-Cell Homeostasis Failure: A Multi-compartmental Analysis in Crohn's Disease
Livia Moreira Genaro

17:10 - 17:20
Association between ultra-processed food consumption, metabolic profile, and intestinal barrier markers in patients with inflammatory bowel disease
Beatriz Gabriela da Costa

17:20 - 17:30
Muscle quality and muscle strength indicators in patients with inflammatory bowel disease
Geisa de Jesus Santos

Voting

17:30 - 18:30
Open topics – 4th to 6th place

Medicine Category

Moderators: Sandro da Costa Ferreira and Daniel Castilho

17:30 - 17:40
Salivary protein profile as a diagnostic tool in Ulcerative Colitis
Anna Luisa Bizotto

17:40 - 17:50
Factors associated with intestinal resection in Crohn's disease patients treated with advanced therapy: a real-world study
Tiago Almeida de Oliveira

17:50 - 18:00
Profile of hospitalizations and outcomes in patients with Inflammatory Bowel Disease
Marcela Maria Silvino Craveiro

Multidisciplinary Category

Moderators: Daniela Magro, Isadora Sayuri Macedo Tuma, and Daniel Castilho

18:00 - 18:10
Cross-cultural adaptation and evaluation of measurement properties of the Nine-Item Avoidant/Restrictive Food Intake Disorder Screen (NIAS) for patients with inflammatory bowel disease or dyspepsia
Alícia Bretas de Castro

18:10 - 18:20
Association between Avoidant/Restrictive Food Intake Disorder and Quality of Life in IBD patients
Amanda Luisa Spiller

18:20 - 18:30
Impact of avoidant/restrictive food intake disorder on nutritional status in individuals with Inflammatory Bowel Disease
Amanda Luisa Spiller

07:00 - 18:30
Congress
07:00 - 07:45
Satellite Symposium 5 – Biopas

Launch of Omvoh®: the arrival of a new IL-23 inhibitor and new therapeutic perspectives for IBD in Brazil

Fernando Magro (Portugal)
Marcello Imbrizi

07:45 - 09:15
Block 5: Challenges of IBD – From Incidence to Daily Practice Strategy


Moderador(a)


 


 

07:45 - 08:00
Global and Latin American IBD Epidemiology: Evolution of Incidence and Prevalence


 

08:00 - 08:15
Colorectal Cancer Surveillance in IBD: Who, When, and How?


 

08:15 - 08:30
T2T in Daily Practice: Feasible in Latin America? Possible Solutions


 

08:30 - 08:45
Costs and Access to Advanced Therapies and System Sustainability


 

08:45 - 09:15
Discussion

09:15 - 09:30
Fibrostenosing Crohn's Disease: Future Perspectives


Apresentador(a)


 

09:30 - 09:45
Therapeutic Pipeline in IBD


Apresentador(a)


 

09:45 - 10:10
Break – Booth Visit

10:10 - 10:55
Satellite Symposium 6 – Abbvie

Beyond the response: Building value with sustained results from SKYRIZI® (risankizumab) in CD

Peter Bossuyt (BELGIUM)
Munique Kurtz

10:55 - 12:25
Block 6: Challenges in Crohn's Disease


Moderador(a)


 


 

10:55 - 11:10
The End of Step-Up? Systematic Advanced Therapy


 

11:10 - 11:25
Does Location Matter? Management of Colonic and Small Bowel CD


 

11:25 - 11:40
Multi-refractory DC: strategies after multiple failures


 

11:40 - 11:55
The End of the "Last Option": A New Era of Surgery in Crohn's Disease


 

11:55 - 12:25
Discussion

12:25 - 14:00
BREAK

12:30 - 13:15
Satellite Symposium 7 – Johnson & Johnson

IL-23 Inhibition in Ulcerative Colitis: lessons from clinical evidence

Anita Afzalii (USA)
Rogério Saad

13:15 - 14:00
Satellite Symposium 8 – Johnson & Johnson

Remittance to persistence: rethinking the therapeutic event of RCU with golimumab

Rodrigo Gasparini
Henrique Dalmolin

14:00 - 15:30
Block 7: Holistic care in complex Crohn's disease


Moderador(a)


 

14:00 - 14:12
Surgical Treatment and Clinical Intractability: Current definition of intractability, timing, and surgical preparation


 

14:12 - 14:24
Ostomy and Quality of Life: Impact of the stoma on young patients, the role of stomatherapy, and social reintegration


 

14:24 - 14:36
Sexuality in Crohn's Disease: Impact on sexual function, dyspareunia vs. psychogenic dysfunction, and clinical management


 

14:36 - 14:48
Obesity: The paradox of post-treatment weight gain, obesity as a pro-inflammatory state, and the impact on the management of biologics


 

14:48 - 15:00
Mental Health: Gut-brain axis, psychiatric impact of stomas/Crohn's disease, and multidisciplinary care


 

15:00 - 15:30
Discussion

15:30 - 15:45
Managing difficult to treat IBD patients


 

15:45 - 16:15
Break – Booth Visit

16:15 - 17:00
Satellite Symposium 9 – Amgen

17:00 - 18:30
Block 8: IBD in Challenging Situations


Moderador(a)


 


 

17:00 - 17:15
IBD in the Elderly: Current Challenges


 

17:15 - 17:30
Pregnancy and IBD: Safe Management


 

17:30 - 17:45
VEO-IBD: Diagnostic and Therapeutic Challenges


 

17:45 - 18:00
Transition of Care


 

18:00 - 18:30
Discussion

18:30 - 20:30
General Assembly

21:00 - 23:59
GEDIIB Institutional Activity

07:00 - 18:00
Scientific Arena
07:00 - 07:45
Sponsored Session – Johnson & Johnson

Top challenges in IBD management

Anita Afzali (USA)
Adam Cheifetz (USA)
Marjorie Argollo

08:15 - 09:30
Module: Surgery in IBD - Part 2: Interactive Case Discussion with Audience

08:15 - 09:30
From Immune Control to Surgical Treatment: Management of Perianal Pyoderma Gangrenosum in Crohn's Disease


Moderador(a)


 


Debatedor(a)


 


 


 


Apresentador(a)


 

08:15 - 09:30
Discussion

09:40 - 10:10
Sponsored Lecture – TAKEDA

The future begins now: the path between the update of the Clinical Protocol and Therapeutic Guidelines (PCDT) and effective access to treatment

Munique Kurtz
Andrea Vieira

10:10 - 12:10
Module: IBD Nursing - Part 2

10:10 - 10:25
What Has Changed in 10 Years for Nursing in Brazil?


 

10:25 - 10:40
IBD and Telenursing


 

10:40 - 10:55
The Wound Ostomy Continence Nurse (WOCN) as Part of the Multidisciplinary IBD Care Team


 

10:55 - 11:10
Social Determinants of Health in IBD Patient Care — They Matter!


 

11:10 - 11:25
Patient Navigation as a Care Tool for IBD Patients


 

11:25 - 11:40
Nursing Assessment Indicator Map in IBD Care: What to Measure?


 

11:40 - 12:10
Discussion


Moderador(a)


 


 

12:10 - 14:10
GEDIIB Youth 2026

12:10 - 13:40
Medicine Category Final


12:10 - 12:40
Ulcerative colitis presenting initially as acute severe colitis during pregnancy: therapeutic challenges in a high-complexity setting
Lawani Rigopoulos

12:40 - 13:10
TAILS in a patient with Crohn's disease: atypical cutaneous presentation, differential diagnosis, and management
Manoela B. Garcia

13:10 - 13:40
Regenerative therapy with adipose-derived stem cells for refractory penetrating perianal Crohn's disease: a case report
Mariana Cabral Chabu

13:40 - 14:10
Presentation of Undergraduate and Multidisciplinary Winners

13:40 - 13:55
Autologous fat grafting for the treatment of complex perianal fistula in Crohn's disease: a case report
Pedro Henrique Silva de Oliveira Souza

13:55 - 14:10
Pericardial effusion associated with anti-TNF use in Crohn's disease: the role of the nurse navigator in the early identification of adverse events
Rebeca Pereira Felberg

14:10 - 14:20
Announcement of Winner – Medicine

14:30 - 15:30
Module: Endoscopy in IBD - Part 3: The Mucosa in 50 Images - Diagnosis, Pitfalls, and Therapeutic Decisions


Moderador(a)


 

14:30 - 14:38
Early Inflammatory Lesions


 

14:38 - 14:46
Structural Lesions in Crohn's Disease


 

14:46 - 14:54
Severe Inflammation


 

14:54 - 15:02
Mucosal Healing and Sequelae


 

15:02 - 15:10
Differential Diagnoses


 

15:10 - 15:30
Discussion

15:45 - 16:15
Sponsored Lecture 6 – AbbVie

Anti-TNF cycling inInflammatory Bowel Diseases

Peter Bossuyt (BELGIUM)

Anti-TNF cycling inInflammatory Bowel Diseases

Peter Bossuyt (BELGIUM)
16:15 - 17:05
Presentation of the Best Industry-Initiated Scientific Papers

Moderators: Genoile Santana and Julio Chebli

16:15 - 16:25
Safety analysis of guselkumab in inflammatory bowel disease in Latin America: data from Phase 2/3 trials in Crohn's disease and ulcerative colitis
Ligia Yukie Sassaki

16:25 - 16:35
Efficacy and Safety of Upadacitinib After 5 Years of Treatment in Patients With Moderately to Severely Active Ulcerative Colitis: Interim Analysis From the Phase 3 U-ACTIVATE Open-label Extension Study
Fernando Jorge Firmino Nobrega

16:35 - 16:45
Efficacy and Safety Up to 3 Years of Risankizumab Maintenance Treatment in Patients With Moderately to Severely Active Ulcerative Colitis: Interim Results from Phase 3 COMMAND Open-Label Extension Study
Renata Filardi Simiqueli Durante

16:45 - 16:55
Efficacy of IL-12/23 and IL-23 Antagonists for Moderate to Severe Crohn’s Disease in Advanced Treatment Failure Populations: A Network Meta-Analysis
Munique Kurtz de Mello

16:55 - 17:05
Efficacy of guselkumab in Latin American adults with moderately to severely active ulcerative colitis: post hoc analysis of the QUASAR and ASTRO studies
Luciana dos Santos Harlacher

17:15 - 18:00
Surgery Module: practical day-to-day decisions


Moderador(a)


 

17:15 - 17:25
LIFT or Flap Advancement for Perianal Crohn's Disease


 

17:25 - 17:35
Symptomatic hemorrhoids in IBD: how do I manage them?


 

17:35 - 17:45
Laser for perianal disease


 

17:45 - 18:00
Discussion

18:00 - 18:30
Adjournment

08:00 - 15:45
Congress
08:00 - 09:30
Block 9: Therapeutic Strategies in Controversial Topics


Moderador(a)


 


 

08:00 - 08:15
Pre-, Peri-, and Postoperative Nutritional Management


 

08:15 - 08:30
Endoscopy in Crohn's Strictures: Limits, Risks, and Outcomes


 

08:30 - 08:45
Management of Brain-Gut Axis Symptoms in IBD


 

08:45 - 09:00
IBD 2025-2026: The Studies That Redefine Treatment


 

09:00 - 09:30
Discussion

09:30 - 09:45
Holistic View of the IBD Patient


 

09:45 - 10:15
Break – Booth Visit

10:15 - 11:00
Satellite Symposium 10 – Ferring

Mesalamine in Mild to Moderate UC: Strategies for Better Outcomes

Adérson Damião
Fábio V. Teixeira

11:00 - 12:30
Block 10: Safety in IBD


Moderador(a)


 


 

11:00 - 11:12
Risk-Benefit Communication of Treatments to Patients


 

11:12 - 11:24
Risks Related to Under- and Overtreatment of IBD


 

11:24 - 11:36
Tuberculosis and the difficulties in diagnosis and choosing treatment


 

11:36 - 11:48
Severe and Opportunistic Infections: Associated Risks


 

11:48 - 12:00
Cancer and IBD: Disease-Related vs. Medication-Related Risk


 

12:00 - 12:30
Discussion

12:30 - 13:15
Break

13:15 - 14:30
Block 11: Miscellaneous


Moderador(a)


 


 

13:15 - 13:30
Diagnostic Challenges: When Not to Think of IBD?


 

13:30 - 13:45
Prediction and Prevention in IBD


 

13:45 - 14:00
Therapeutic Sequencing in IBD: Science or Trial and Error?


 

14:00 - 14:15
Predictive Biomarkers of Therapeutic Response


 

14:15 - 14:30
Discussion

14:30 - 15:30
Block 12: Beyond the Gut


Moderador(a)


 


 

14:30 - 14:42
Dermatology in IBD: Manifestations vs. Adverse Events


 

14:42 - 14:54
Arthritis Associated with IBD: Differential from Spondyloarthritis


 

14:54 - 15:06
Cardiovascular Risk in IBD


 

15:06 - 15:18
Anemia: From Diagnosis to Treatment


 

15:18 - 15:30
Discussion

15:30 - 15:45
Closing Ceremony

08:00 - 17:00
Scientific Arena
08:00 - 09:30
Module: Endoscopy in IBD - Part 4: Mucosa at the Center of Decisions - Multidisciplinary Case Discussion


Moderador(a)


 

08:00 - 08:15
Endoscopist: Findings, Classification, Lesions, Diagnosis (do they change therapeutic strategy?)


 

08:15 - 08:30
Radiologist: Best imaging modality, inflammation vs. fibrosis, complications — confirms or changes endoscopic interpretation?

08:30 - 08:45
Pathologist: Main histological findings, inflammatory activity, dysplasia


 

08:45 - 09:00
Surgeon: Surgical perspective, ideal timing for surgery


 

09:00 - 09:30
Discussion

09:45 - 10:15
Surgery Module: Patient-centered care

09:45 - 09:55
A holistic view of care in IBD


 

09:55 - 10:05
The patient at the center of care: from theory to practice


 

10:05 - 10:15
Discussion

10:15 - 11:00
Closing Session